"Endotherapy Devices Industry Set for $7 Billion Growth by 2030"

Meticulous Research®, a renowned global market research company, is pleased to announce the publication of its latest report titled, "Endotherapy Devices Market by Type (Needles, Biopsy Forceps, Balloon Dilators, Hemostasis, Snares, Catheters, Sphincterotomes, Guide Wires, Stents, Retrieval Nets), Application (Upper GI Endoscopy, Colonoscopy, Cystoscopy) – Global Forecast to 2030."
Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5528?utm_source=sb&utm_medium=social&utm_campaign=product&utm_content=16-05-2024
The report predicts that the global endotherapy devices market will achieve a valuation of $7 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030. This growth trajectory is driven by several factors including the increasing incidence of diseases necessitating endoscopic procedures, a rising prevalence of gastrointestinal disorders, a growing preference for minimally invasive surgeries, advancements in endotherapy technology, and an expanding elderly population.
However, market expansion is tempered by the high costs associated with endotherapy devices and the potential for device-related infections. Despite these challenges, emerging markets present significant growth opportunities, although a shortage of trained professionals could impede market progress.
Key Market Players: Prominent companies in the endotherapy devices market include:
Boston Scientific Corporation (U.S.), Olympus Corporation (Japan), Medtronic plc (U.S.), FUJIFILM Holdings Corporation (Japan), Cook Group Incorporated (U.S.), Conmed Corporation (U.S.), Hoya Corporation (Japan), Stryker Corporation (U.S.), KARL STORZ SE & Co. KG (Germany), Smith & Nephew PLC (U.K.), Micro-Tech (Nanjing) Co., Ltd. (China), Nipro Corporation (Japan), MEDIVATORS B.V. (Germany), The Cooper Companies, Inc. (U.S.), JOHNSON & JOHNSON (U.S.)